Cargando…

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma

Colorectal carcinoma (CRC) is a prevalent cancer worldwide with a high mortality rate. Evidence suggests that increased expression of Cyclin-dependent kinase 5 (CDK5) contributes to cancer progression, making it a promising target for treatment. This study examined the efficacy of selectively inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amin, Niranjana, Wang, Herui, Song, Qi, Bhaskar, Manju, Yadav, Sharda Prasad, Gilbert, Mark R., Pant, Harish, Tabouret, Emeline, Zhuang, Zhengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380212/ https://www.ncbi.nlm.nih.gov/pubmed/37511490 http://dx.doi.org/10.3390/ijms241411733

Ejemplares similares

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma
por: Tabouret, Emeline, et al.
Publicado: (2020)

Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease
por: Binukumar, BK., et al.
Publicado: (2015)

Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in in vitro and in vivo models of Parkinson’s disease
por: Tran, Judith, et al.
Publicado: (2021)

Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein
por: Binukumar, B.K., et al.
Publicado: (2015)

The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35
por: Amin, Niranjana D., et al.
Publicado: (2016)

Phosphorylation, Dephosphorylation, and Multiprotein Assemblies Regulate Dynamic Behavior of Neuronal Cytoskeleton: A Mini-Review
por: Kurochkina, Natalya, et al.
Publicado: (2018)

Cdk5 Inhibitory Peptide (CIP) Inhibits Cdk5/p25 Activity Induced by High Glucose in Pancreatic Beta Cells and Recovers Insulin Secretion from p25 Damage
por: Zheng, Ya-Li, et al.
Publicado: (2013)

TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease
por: Binukumar, BK, et al.
Publicado: (2016)

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
por: Demelash, Abeba, et al.
Publicado: (2012)

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
por: Zheng, Ya-Li, et al.
Publicado: (2016)

Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(−/−) Mice
por: Contreras-Vallejos, Erick, et al.
Publicado: (2014)

Cdk5 and aberrant cell cycle activation at the core of neurodegeneration
por: Requejo-Aguilar, Raquel
Publicado: (2022)

Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
por: Prochazkova, Michaela, et al.
Publicado: (2013)

Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
por: Crews, L, et al.
Publicado: (2011)

Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
por: Shukla, Arvind Kumar, et al.
Publicado: (2019)

Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
por: Shukla, Arvind Kumar, et al.
Publicado: (2021)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

Premature Cdk1/Cdc5/Mus81 pathway activation induces aberrant replication and deleterious crossover
por: Szakal, Barnabas, et al.
Publicado: (2013)

Cdk5 protects huntingtin
por: LeBrasseur, Nicole
Publicado: (2005)

Three decades of Cdk5
por: Pao, Ping-Chieh, et al.
Publicado: (2021)

Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome
por: Wang, Herui, et al.
Publicado: (2018)

The CDK5 repressor CDK5RAP1 is a methylthiotransferase acting on nuclear and mitochondrial RNA
por: Reiter, Veronika, et al.
Publicado: (2012)

Cdk5 deficiency and neurodegeneration in flies
Publicado: (2012)

The role of Cdk5 in neurological disorders
por: Ao, Chuncao, et al.
Publicado: (2022)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes
por: Pao, Ping-Chieh, et al.
Publicado: (2023)

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons
por: Veas-Pérez de Tudela, Miguel, et al.
Publicado: (2015)

Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke
por: Tuo, Qing-Zhang, et al.
Publicado: (2018)

Investigations on the Wound Healing Potential of Tilapia Piscidin (TP)2-5 and TP2-6
por: Liu, Chia-Wen, et al.
Publicado: (2022)

Cyclin-dependent kinase 5 (CDK5) regulates the circadian clock
por: Brenna, Andrea, et al.
Publicado: (2019)

Cdk5 and the mystery of synaptic vesicle endocytosis
por: Nguyen, Chan, et al.
Publicado: (2003)

Physiological and pathological phosphorylation of tau by Cdk5
por: Kimura, Taeko, et al.
Publicado: (2014)

CDK5: A new lead to survival
por: Lew, John
Publicado: (2013)

CDK5 opens the way for DLC1
por: Short, Ben
Publicado: (2014)

Cdk5: An Emerging Kinase in Pain Signaling
por: Pareek, Tej Kumar, et al.
Publicado: (2012)

The Role of CDK5 in Tumours and Tumour Microenvironments
por: Do, Phuong Anh, et al.
Publicado: (2020)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Altered expression of the Cdk5 activator-like protein, Cdk5α, causes neurodegeneration, in part by accelerating the rate of aging
por: Spurrier, Joshua, et al.
Publicado: (2018)

Deficiency of Parkinson’s Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry
por: López-Grueso, María José, et al.
Publicado: (2022)

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
por: Park, Silvia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nna4hk4hgvddd6ke1f9cecjpa0